JP2022504722A5 - - Google Patents

Info

Publication number
JP2022504722A5
JP2022504722A5 JP2021519858A JP2021519858A JP2022504722A5 JP 2022504722 A5 JP2022504722 A5 JP 2022504722A5 JP 2021519858 A JP2021519858 A JP 2021519858A JP 2021519858 A JP2021519858 A JP 2021519858A JP 2022504722 A5 JP2022504722 A5 JP 2022504722A5
Authority
JP
Japan
Prior art keywords
inhibitor
growth medium
hat
hdac
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021519858A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022504722A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/056145 external-priority patent/WO2020077343A1/en
Publication of JP2022504722A publication Critical patent/JP2022504722A/ja
Publication of JP2022504722A5 publication Critical patent/JP2022504722A5/ja
Priority to JP2024099903A priority Critical patent/JP2024137954A/ja
Pending legal-status Critical Current

Links

JP2021519858A 2018-10-12 2019-10-14 造血幹細胞および造血前駆細胞の増殖システム Pending JP2022504722A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024099903A JP2024137954A (ja) 2018-10-12 2024-06-20 造血幹細胞および造血前駆細胞の増殖システム

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862745208P 2018-10-12 2018-10-12
US62/745,208 2018-10-12
US201962854250P 2019-05-29 2019-05-29
US62/854,250 2019-05-29
PCT/US2019/056145 WO2020077343A1 (en) 2018-10-12 2019-10-14 Hematopoietic stem and progenitor cell expansion system

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024099903A Division JP2024137954A (ja) 2018-10-12 2024-06-20 造血幹細胞および造血前駆細胞の増殖システム

Publications (2)

Publication Number Publication Date
JP2022504722A JP2022504722A (ja) 2022-01-13
JP2022504722A5 true JP2022504722A5 (https=) 2022-10-20

Family

ID=68426859

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021519858A Pending JP2022504722A (ja) 2018-10-12 2019-10-14 造血幹細胞および造血前駆細胞の増殖システム
JP2024099903A Pending JP2024137954A (ja) 2018-10-12 2024-06-20 造血幹細胞および造血前駆細胞の増殖システム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024099903A Pending JP2024137954A (ja) 2018-10-12 2024-06-20 造血幹細胞および造血前駆細胞の増殖システム

Country Status (6)

Country Link
US (1) US20210386787A1 (https=)
EP (1) EP3863648A1 (https=)
JP (2) JP2022504722A (https=)
KR (1) KR20210076048A (https=)
CN (1) CN112805015A (https=)
WO (1) WO2020077343A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024539519A (ja) * 2021-10-20 2024-10-28 エクシール, インク. 非ヒト霊長類の個別化されたゲノムアセンブリ及び人工多能性幹細胞株を前臨床評価に使用するための組成物及び方法
CN114891749B (zh) * 2022-07-13 2022-12-02 杭州艾名医学科技有限公司 一种胰腺癌类器官的培养基及胰腺癌类器官的培养方法
CN115975929A (zh) * 2022-08-18 2023-04-18 南通大学 Kat2a抑制剂在治疗脊髓及坐骨神经损伤中的应用
CN115644066B (zh) * 2022-12-02 2024-01-16 福建农林大学 利用外源多胺提高龙眼胚性愈伤组织生长量和类黄酮含量的方法
LU507930B1 (en) * 2024-08-05 2026-02-05 Luxembourg Institute Of Science And Tech Serum-free culture medium for the culture of human monocytic cells and method using the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1170008A1 (en) * 2000-07-07 2002-01-09 Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus Valproic acid and derivatives thereof as histone deacetylase inhibitors
JP2009509911A (ja) * 2005-05-05 2009-03-12 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ リンパ造血組織を定着させるためのmapcまたはそれらの子孫の使用
KR20110019727A (ko) * 2008-04-07 2011-02-28 뉴포텐셜, 인크. Rna 간섭을 통한 다능 유전자의 유도에 의한 세포 재프로그래밍
JP5694946B2 (ja) * 2008-12-03 2015-04-01 インターナショナル ステム セル コーポレイション 幹細胞から分化細胞を得る方法
WO2010108126A2 (en) * 2009-03-19 2010-09-23 Fate Therapeutics, Inc. Reprogramming compositions and methods of using the same
WO2011158806A1 (ja) * 2010-06-14 2011-12-22 日産化学工業株式会社 造血幹細胞の製造方法
WO2011159684A2 (en) * 2010-06-15 2011-12-22 Cellular Dynamics International, Inc. Generation of induced pluripotent stem cells from small volumes of peripheral blood
ES2769270T3 (es) * 2011-09-30 2020-06-25 Bluebird Bio Inc Compuestos para transducción viral mejorada
WO2013086029A1 (en) * 2011-12-05 2013-06-13 Primorigen Biosciences Inc. Compositions and methods for differentiating pluripotent stem cells into primitive blood cells and uses thereof
EP2982745A1 (en) * 2014-08-06 2016-02-10 Johann Wolfgang Goethe-Universität, Frankfurt am Main Method for expanding immune cells
US10669528B2 (en) * 2015-06-25 2020-06-02 Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
EP4049665B1 (en) * 2016-03-15 2025-03-12 The Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion
WO2018160028A1 (ko) * 2017-03-02 2018-09-07 주식회사 셀라토즈테라퓨틱스 신경세포 분화용 배지 조성물 및 상기 배지 조성물을 이용한 체세포로부터 신경세포로의 분화 방법

Similar Documents

Publication Publication Date Title
JP2022504722A5 (https=)
Stark et al. The metabolic requirements of Th2 cell differentiation
Pritchard et al. Lipids in breast carcinogenesis
Zhu et al. 1, 25‑Dihydroxyvitamin D regulates macrophage polarization and ameliorates experimental inflammatory bowel disease by suppressing miR-125b
CN107454913B (zh) 使用小分子的人成纤维细胞至神经干细胞的直接转化方法
JP5931277B2 (ja) 幹細胞の破砕及び凝集防止方法及び組成物
JP5926447B2 (ja) 血管内投与に適した大きさを持つ幹細胞の製造方法
Hubbard et al. Alteration of murine mammary tumorigenesis by dietary enrichment with n-3 fatty acids in fish oil
Hurt et al. Growth, reproduction, and tissue concentrations of selenium in the selenium-depleted rat
JP2024137954A (ja) 造血幹細胞および造血前駆細胞の増殖システム
Miyamoto et al. Neoplastic transformation of mouse mammary epithelial cells by in vitro exposure to N-methyl-N-nitrosourea.
WO2010096264A2 (en) Methods for enhancing hematopoietic stem/progenitor cell engraftment
JP2016519142A (ja) 静脈投与用幹細胞組成物
JP2015510503A (ja) 遊離基による損害を減少するための医薬組成物
RU2455354C1 (ru) Композиция для регенерации клеток кожи и слизистых оболочек
US10159697B2 (en) Methods for enhancing hematopoietic stem/progenitor cell engraftment
CN103193852A (zh) 用于治疗结肠癌的化合物及其制备方法
JP5275711B2 (ja) 幹細胞から分化誘導した角化細胞及び人工表皮シート
CN115960830B (zh) 丁酸钠在促进神经干细胞增殖中的用途
CN113373108A (zh) 一种表皮干细胞扩增培养基及其制备方法和应用
US20250241961A1 (en) Stem cell immunotherapy for colitis
JP2017222581A (ja) 肝臓組織再生用組成物
DUNHAM et al. Intradermal transplantation of hepatoma-cells in guinea-pigs-A model of early cancer
Park et al. Urine-Derived Stem Cell Administration Attenuates Renal Injury in an Adriamycin-Induced Nephropathy: SA-PO349
Choi et al. Exploring the Metabolic Reprogramming